RLRL Therapeutic Feasibility and Potential Mechanism on Myopia
International Journal of Molecular Sciences · 31.12.2025 · 27 (1) · 428
DOI: 10.3390/ijms27010428 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.12.2025. Verfasst von Yu-Jiao Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Optometry, Dongshin University, Naju 58245, Jeonnam, Republic of Korea. Hauptthemen laut MEDLINE: Myopia, Low-Level Light Therapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Myopia is a major global public health concern, with a particularly high and increasing prevalence in East Asia. Although significant progress has been made in regard to developing strategies to slow the progression of myopia, the precise biological mechanisms underlying the onset and progression of myopia remain unclear. Repeated low-level red light (RLRL) therapy, a novel non-invasive photobiomodulation (PBM) technique, has demonstrated promising efficacy for controlling axial elongation and refractive error progression. This review first outlines the clinical definition, epidemiology, and global health impact of myopia, followed by the etiology-based pathogenesis and corresponding intervention strategies. Special attention has been given to emerging mechanistic evidence supporting RLRL, particularly its role in activating mitochondrial cytochrome c oxidase (CCO), enhancing retinal metabolism, influencing choroidal changes in blood perfusion and thickness, and in scleral remodeling. Finally, the feasibility and potential mechanism of the RLRL therapy for slowing myopia progression have been discussed from the perspective of safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Optometry, Dongshin University, Naju 58245, Jeonnam, Republic of Korea.
- Biomedicine, Health and Life Convergence Sciences, BK21 Four, College of Pharmacy, Mokpo National University, Muan 58554, Jeonnam, Republic of Korea.
- College of Korean Medicine, Dongshin University, Naju 58245, Jeonnam, Republic of Korea.
ORCID-Profile: Seung-Sik Cho, Dae-Hun Park
Zitieren
APA
Chen, Y. J., Jeon, I. C., Cho, S. S., & Park, D. H. (2025). RLRL Therapeutic Feasibility and Potential Mechanism on Myopia. International Journal of Molecular Sciences, 27(1), 428. https://doi.org/10.3390/ijms27010428
Vancouver
Chen YJ, Jeon IC, Cho SS, Park DH. RLRL Therapeutic Feasibility and Potential Mechanism on Myopia. International Journal of Molecular Sciences. 2025;27(1):428. doi:10.3390/ijms27010428
BibTeX
@article{Chen2025,
author = {Chen, Yu-Jiao and Jeon, In-Chul and Cho, Seung-Sik and Park, Dae-Hun},
title = {RLRL Therapeutic Feasibility and Potential Mechanism on Myopia},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {27},
number = {1},
pages = {428},
doi = {10.3390/ijms27010428}
}
EUVIMED